title: The adaptor protein p66Shc inhibits mTOR-dependent anabolic metabolism.
abstract: Adaptor proteins link surface receptors to intracellular signaling pathways and potentially control the way cells respond to nutrient availability. Mice deficient in p66Shc, the most recently evolved isoform of the Shc1 adaptor proteins and a mediator of receptor tyrosine kinase signaling, display resistance to diabetes and obesity. Using quantitative mass spectrometry, we found that p66Shc inhibited glucose metabolism. Depletion of p66Shc enhanced glycolysis and increased the allocation of glucose-derived carbon into anabolic metabolism, characteristics of a metabolic shift called the Warburg effect. This change in metabolism was mediated by the mammalian target of rapamycin (mTOR) because inhibition of mTOR with rapamycin reversed the glycolytic phenotype caused by p66Shc deficiency. Thus, unlike the other isoforms of Shc1, p66Shc appears to antagonize insulin and mTOR signaling, which limits glucose uptake and metabolism. Our results identify a critical inhibitory role for p66Shc in anabolic metabolism.
authors.affiliation: 1Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Soliman
authors.forename: Anas M
authors.initials: AM
authors.lastname: Abdel Rahman
authors.forename: Dudley W
authors.initials: DW
authors.lastname: Lamming
authors.forename: Dudley A
authors.initials: DA
authors.lastname: Lamming
authors.forename: Kivanç
authors.initials: K
authors.lastname: Birsoy
authors.forename: Judy
authors.initials: J
authors.lastname: Pawling
authors.forename: Maria E
authors.initials: ME
authors.lastname: Frigolet
authors.forename: Huogen
authors.initials: H
authors.lastname: Lu
authors.forename: I George
authors.initials: IG
authors.lastname: Fantus
authors.forename: Adrian
authors.initials: A
authors.lastname: Pasculescu
authors.forename: Yong
authors.initials: Y
authors.lastname: Zheng
authors.forename: David M
authors.initials: DM
authors.lastname: Sabatini
authors.forename: James W
authors.initials: JW
authors.lastname: Dennis
authors.forename: Tony
authors.initials: T
authors.lastname: Pawson
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D005947:Glucose / Q000235:genetics / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects / Q000502:physiology*; D006367:HeLa Cells; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D055765:Shc Signaling Adaptor Proteins / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D020123:Sirolimus / Q000494:pharmacology; D000071425:Src Homology 2 Domain-Containing, Transforming Protein 1; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
chemical_list: D000903:Antibiotics, Antineoplastic; C528024:SHC1 protein, human; D055765:Shc Signaling Adaptor Proteins; C528034:Shc1 protein, mouse; D000071425:Src Homology 2 Domain-Containing, Transforming Protein 1; C546842:MTOR protein, human; C546843:mTOR protein, mouse; D058570:TOR Serine-Threonine Kinases; D005947:Glucose; D020123:Sirolimus